Cardiovascular Disease and Diabetes

Cardiovascular Disease and Diabetes

You have access
Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study
Nathan D. Wong, Yanglu Zhao, Rohini Patel, Christopher Patao, Shaista Malik, Alain G. Bertoni, Adolfo Correa, Aaron R. Folsom, Sumesh Kachroo, Jayanti Mukherjee, Herman Taylor, Elizabeth Selvin

Diabetes Care May 2016, 39 (5) 668-676; DOI: 10.2337/dc15-2439
Open Access
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, Mark Woodward, Qiang Li, Mark E. Cooper, Pavel Hamet, Stephen Harrap, Simon Heller, Stephen MacMahon, Giuseppe Mancia, Michel Marre, David Matthews, Bruce Neal, Neil Poulter, Anthony Rodgers, Bryan Williams, Sophia Zoungas

Diabetes Care May 2016, 39 (5) 694-700; DOI: 10.2337/dc15-2322
You have access
Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes
The ACCORD Study Group

Diabetes Care May 2016, 39 (5) 701-708; DOI: 10.2337/dc15-2283
You have access
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group

Diabetes Care May 2016, 39 (5) 686-693; DOI: 10.2337/dc15-1990
Open Access
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Mauro Gori, Deepak K. Gupta, Brian Claggett, Elizabeth Selvin, Aaron R. Folsom, Kunihiro Matsushita, Natalie A. Bello, Susan Cheng, Amil Shah, Hicham Skali, Orly Vardeny, Hanyu Ni, Christie M. Ballantyne, Brad C. Astor, Barbara E. Klein, David Aguilar, Scott D. Solomon

Diabetes Care May 2016, 39 (5) 677-685; DOI: 10.2337/dc15-1760
You have access
Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
ORIGIN Trial Investigators

Diabetes Care May 2016, 39 (5) 709-716; DOI: 10.2337/dc15-1676
You have access
Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study
Alex Z. Fu, Stephen S. Johnston, Ameen Ghannam, Katherine Tsai, Katherine Cappell, Robert Fowler, Ellen Riehle, Ashley L. Cole, Iftekhar Kalsekar, John Sheehan

Diabetes Care May 2016, 39 (5) 726-734; DOI: 10.2337/dc15-0764
You have access
Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess?
Robert J. Smith, Allison B. Goldfine, William R. Hiatt

Diabetes Care May 2016, 39 (5) 738-742; DOI: 10.2337/dc15-2237
Open Access
DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty
Kristian B. Filion, Samy Suissa

Diabetes Care May 2016, 39 (5) 735-737; DOI: 10.2337/dci15-0036
You have access
SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
Muhammad Abdul-Ghani, Stefano Del Prato, Robert Chilton, Ralph A. DeFronzo

Diabetes Care May 2016, 39 (5) 717-725; DOI: 10.2337/dc16-0041

Main menu

User menu

Search

Cardiovascular Disease and Diabetes

Pages

Navigate

More Information

Other ADA Resources